Home
>>
Products
>>
Antibodies
>>
Recombinant Antibodies
>
Anti-Human HLA-DRB Recombinant Antibody

Anti-Human HLA-DRB Recombinant Antibody

Product Number

YR1018

Alias

科研级 Apolizumab ( 阿泊珠单抗 ), Anti-HLA-DRB Recombinant Antibody, Research Grade Apolizumab

Specifications
  • 1mg
  • 5mg
Product Description
Alias科研级 Apolizumab ( 阿泊珠单抗 ), Anti-HLA-DRB Recombinant Antibody, Research Grade Apolizumab
Catalog NumberYR1018
Molecular NameApolizumab
Size1mg, 5mg
ClonityMonoclonal
Purity>95% as determined by SDS-PAGE
Concentration1mg/ml
Antibody IsotypeIgG1
FormulationPBS, pH7.5
BackgroundApolizumab is a humanized monoclonal antibody intended for use in hematologic cancers. Development was abandoned in 2005 because of toxic effects and lack of efficacy in human patients. The observed dose limiting toxic effects were aseptic meningitis and hemolytic uremia. There are no current clinical trials into its use.
CAS Number267227-08-7
ApplicationELISA, IP, FCM, FuncS, Neut, IF, ICC
Storage ConditionIt is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
RemarksThis product is for research use only.
Shipping ConditionShipped on ice packs.
TargetHLA-DRB[Homo sapiens]

Login

Don’t have an account?Sign Up Now

Register

Already have an account?Log In Now

Inquire Now